Many biomarkers have been proposed as early markers of AKI, which may be useful for the detection of AKI before increases in serum creatinine, neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), IL-18, cystatin C, liver-type fatty acid-binding protein, monocyte chemoattractant protein 1 (MCP-1), prepro-epidermal growth factor (EGF), and urinary components of renin-angiotensin system [9–16]. This evidence concerns the gene CST3 and acute kidney injury.